OGEN insider transaction filings
ORAGENICS INC — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-07. Screen OGEN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Spencer John — Chief Financial Officer | Grant/award (A): 55,900 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4/A | Telling Fred — Director | Sale (S): 210 @ $0.94 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Huffman Janet — CEO and CFO | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Telling Fred — Director | Sale (S): 210 @ $0.94 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Giordano Natasha — Director | Grant/award (A): 38,320 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | DUNTON ALAN W — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | KOSKI ROBERT C — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | GANDOLFO JOHN P — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | POPE CHARLES L — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Odyssey Health, Inc. — 10% owner | Sale (S): 2,000 @ $4.46 · Sale (S): 5,044 @ $4.26 | EDGAR |
| 2025-06-16 | 4 | Odyssey Health, Inc. — 10% owner | Sale (S): 5,000 @ $4.27 · Sale (S): 5,000 @ $4.45 | EDGAR |
Recent 8-K events — ORAGENICS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OGEN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →